Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
9.12
-0.23 (-2.46%)
Nov 4, 2024, 4:00 PM EST - Market closed
Novavax Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Novavax stock have an average target of 17.83, with a low estimate of 9.00 and a high estimate of 26. The average target predicts an increase of 95.50% from the current stock price of 9.12.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Novavax stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 3 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Maintains $31 → $25 | Strong Buy | Maintains | $31 → $25 | +174.12% | Oct 16, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $23 → $26 | Strong Buy | Reiterates | $23 → $26 | +185.09% | Oct 10, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $31 | Strong Buy | Maintains | $31 | +239.91% | Oct 2, 2024 |
| B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $25 → $23 | Strong Buy | Reiterates | $25 → $23 | +152.19% | Aug 12, 2024 |
| JP Morgan | JP Morgan | Sell Maintains $8 → $9 | Sell | Maintains | $8 → $9 | -1.32% | Aug 12, 2024 |
Financial Forecast
Revenue This Year
776.69M
from 983.71M
Decreased by -21.04%
Revenue Next Year
556.85M
from 776.69M
Decreased by -28.30%
EPS This Year
-0.82
from -5.41
EPS Next Year
-0.17
from -0.82
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 839.5M | 1.0B | 982.7M | ||
| Avg | 776.7M | 556.9M | 659.1M | ||
| Low | 710.8M | 226.4M | 348.4M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -14.7% | 33.0% | 76.5% | ||
| Avg | -21.0% | -28.3% | 18.4% | ||
| Low | -27.7% | -70.9% | -37.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.13 | 2.16 | 2.46 | ||
| Avg | -0.82 | -0.17 | 0.91 | ||
| Low | -1.17 | -1.63 | -0.53 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.